Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Primary Care

 

Sub-Saharan Africa ‘ready for investment’

HBI reports from the Sub-Saharan Africa panel at HBI 2019, where Teo Sarda, CEO of Sphera, Dr Shrey Viranna, CEO of Life, and Audrey Obara, head of healthcare for Swedfund, talked about how to sustainably invest in Africa. 

Can pan-Nordic synergies really exist?

Three of the Nordic's largest operators took to the stage at HBI 2019 to speak about pan-Nordic collaboration. Here's what Fredrik Gren, CEO of Ambea, Alexander Wennergren Helm, CEO of Aleris, and Yrjö Närnhinen, CEO of Terveystalo, said.

FREE BLOG Ten more things we learned at HBI 2019

Here are 10 more things that piqued our interest at HBI 2019, where sector stakeholders from payors to investors come together to grapple with the biggest and most interesting issues of the year.

Wafer-thin health care service profits at Bupa

Why did Bupa, the international health insurer which is also one of the largest health care service players outside of the USA, announce its 2018 results so quietly that HBI isn't aware of any UK daily reporting them this year? The figures show that Bupa's £3.37bn of revenue from nursing homes, hospitals, dentistry and primary care across a dozen countries, barely made money. Could this be down to its interesting governance structure?

FREE BLOG Things we learned at HBI 2019

This week delegates from around the world descended on London for HBI 2019 to discuss the healthcare market and its various sub-sectors. Here are the things we learnt:

Big South African hospital groups look to affordable care for masses

The new(ish) CEOs of Life and Mediclinic are keen to engage beyond their traditional elite markets of around 9m people. We look at new affordable models and where they could be exported beyond the rainbow nation. Both Life's Shrey Viranna and Mediclinic's Ronnie Van Der Merwe were at HBI 2019.

Ukraine healthcare reform in doubt

The future of Ukraine's wide-sweeping healthcare reforms is in doubt after political manoeuvres to oust the country's acting health minister. 

IPOs no-show as market slows

Two of Europe’s biggest healthcare companies which were widely expected to IPO imminently are now, we hear, ruling out this year. Why the delay – and what does this tell us about the state of a slowing market? HBI speaks to an operator CEO and investment banking sources.

Find Us